Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

108.90
+0.09500.09%
Volume:1.81M
Turnover:198.98M
Market Cap:135.46B
PE:23.02
High:110.90
Open:109.87
Low:108.76
Close:108.80
Loading ...

Gilead Sciences Inc. Stock Rises 3.6%, Outperforms Competitors

Dow Jones
·
20 May

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2025-05-19

Reuters
·
19 May

Novavax Boosts Vaccine Stocks; Gold Stocks and Long VIX ETFs Jump After US Downgrade

Tiger Newspress
·
19 May

Compugen Ltd. Reports Slight Decline in Q1 2025 Revenues to $2.3M; Net Loss Narrowly Improves to $7.2M with EPS at $0.08

Reuters
·
19 May

Gilead Sciences CFO Andrew D. Dickinson Reports Disposal of Common Shares

Reuters
·
17 May

Stock Track | Gilead Sciences Surges 5% Pre-Market Despite Trump's Drug Price Cut Announcement

Stock Track
·
16 May

Gilead Sciences Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
16 May

Gilead Sciences Announces Breakthrough Data in Metastatic Triple-Negative Breast Cancer and Multiple Myeloma at 2025 ASCO and EHA

Reuters
·
16 May

BRIEF-Gilead And Kite Announce Presentation Of Transformative Data In 1L Metastatic Triple-Negative Breast Cancer, Updated Results In Multiple Myeloma And Early Data From Novel Investigational CAR T-Cell Therapy Targeting Brain Cancer At 2025 ASCO And EHA

Reuters
·
16 May

Gilead and Kite Announce Presentation of Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational Car T-Cell Therapy Targeting Brain Cancer at 2025 Asco and Eha

THOMSON REUTERS
·
16 May

Gilead Sciences Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
15 May

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
13 May

BUZZ-US drugmakers rise as Trump plans broad drug price cuts in executive order

Reuters
·
12 May

Stock Track | Gilead Sciences Surges 5% Pre-Market Despite Trump's Drug Price Cut Announcement

Stock Track
·
12 May

Pfizer up 2.8%, Eli Lilly up 2.9%, Merck up 4.5%, Gilead Sciences up 4.3%, Abbvie up 1.4%

THOMSON REUTERS
·
12 May

Shares of U.S. Pharma Companies Reverse Premarket Course

THOMSON REUTERS
·
12 May

Trump Says He Will Cut Drug Prices by 59%

Reuters
·
12 May

Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
10 May

BRIEF-Gilead Sciences Inc - Stockholders Reject Dei Practices Risk Report Proposal For Contractors - SEC Filing

Reuters
·
09 May

Gilead Sciences Inc - Stockholders Reject Dei Practices Risk Report Proposal for Contractors - SEC Filing

THOMSON REUTERS
·
09 May